Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126193191 | 12619319 | 1 | I | 20160728 | 20160803 | 20160803 | EXP | US-AMGEN-USASP2016098603 | AMGEN | 0.00 | F | Y | 0.00000 | 20160803 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126193191 | 12619319 | 1 | PS | EPOGEN | ERYTHROPOIETIN | 1 | Unknown | UNK, UNK | 103234 | UNKNOWN FORMULATION | |||||||||
| 126193191 | 12619319 | 2 | SS | EPOGEN | ERYTHROPOIETIN | 1 | 103234 | UNKNOWN FORMULATION | |||||||||||
| 126193191 | 12619319 | 3 | C | METOPROLOL. | METOPROLOL | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126193191 | 12619319 | 1 | Anaemia |
| 126193191 | 12619319 | 2 | End stage renal disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126193191 | 12619319 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126193191 | 12619319 | Cardiovascular insufficiency | |
| 126193191 | 12619319 | Dark circles under eyes | |
| 126193191 | 12619319 | Vein disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126193191 | 12619319 | 1 | 1995 | 0 |